Search bioRxiv⌕ Search

Biology subjects

Douglas-Green, S. A.

Publications and source records attributed to Douglas-Green, S. A..

4 recordsLinked to original sources

ProCAST: A Bioinformatics Suite for Mass Spectrometry-Based Protein Corona Proteomics Analysis

When nanoparticles are exposed to biological fluids, they spontaneously adsorb proteins, forming a protein corona that defines their biological identity and dictates cellular uptake, biodistribution, and toxicity. Characterizing protein coronas includes using proteomics approaches (e.g., LC-MS/MS) to identify proteins and generate vast lists of adsorbed proteins, often visualized via complex heatmaps. While heatmaps display data they do not offer heuristic guide, leaving the driving mechanisms of adsorption unknown. Moreover, interpretation of protein corona proteomics data remains limited by fragmented workflows, inconsistent preprocessing, and visual outputs that are often descriptive rather than readily interpretable. These conventional methods identify adsorbed proteins but fail to explain why specific proteins are selected or how they influence the particles biological fate. Here, we developed ProCAST (Protein Corona Analysis and Statistical Tool), an R-based framework for protein corona proteomics that integrates proteomics data, nanoparticle metadata, protein annotations, and multi-level visualization within a single analytical workflow. ProCAST facilitates abundant protein clustering based on sample conditions, sequence descriptors, property or protein correlations, and gene ontology-based functional visualization. It also distinguishes abundant proteins from frequent proteins, providing distinct layers of information from the same dataset. ProCAST was used to re-analyze previously published PAMAM G4 dendrimer-FBS datasets, demonstrating that ProCAST reproduces descriptor-level visualizations and offers new insights through clearer comparisons of functional patterns and hypothesis generation from dominant corona proteins. By organizing results as complementary views of the same dataset, ProCAST facilitates the shift of protein corona analysis from descriptive outputs toward structured, comparative, and experimentally testable interpretations.

bioinformatics↗

Layer-by-Layer Nanoparticle Outer Polyion Impacts Protein Corona Formation

Nanoparticles (NPs) can be engineered to achieve targeted delivery with strategies based on surface modifications. These include layer-by-layer (LbL) NPs, modular electrostatically assembled carriers with tunable surface properties altered by changes to the outer polyion layer. Variations in these polymers dictate intracellular trafficking and biodistribution patterns. As NPs are administered, a layer of protein adsorbs to their surfaces, forming a protein corona that affects NP properties, alters biodistribution, and ultimately, impacts therapeutic efficacy. We hypothesized that some differences in LbL NP performance are due, in part, to variations in the resulting protein coronas. To study them, we first optimized an ultrafiltration method to effectively isolate LbL NPs with their protein corona. Following incubation in conditioned media, anionic homopolypeptide outer layers, such as poly-L-aspartic acid (PLD) and poly-L-glutamic acid (PLE), and LbL NPs with the bioinert polymer poly(acrylic acid) (PAA) had the lowest amount of protein associated, lower than conventional PEG liposomes. While mass spectroscopy revealed changes in the protein composition among LbL NPs; albumin, alpha-2-macroglobulin, and apolipoprotein B were most abundant. In vitro, pre-formed protein coronas reduced uptake in macrophages but increased uptake in ovarian cancer cells for certain LbL NP outer layers. In vivo, LbL NP outer layer influenced both serum half-life and biodistribution. Overall, this work highlights that LbL NPs can be designed to control protein corona formation, and supports that further understanding NP interactions with biological fluids is essential for designing clinically translatable NP platforms. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=181 SRC="FIGDIR/small/670086v1_ufig1.gif" ALT="Figure 1"> View larger version (50K): org.highwire.dtl.DTLVardef@18a2a66org.highwire.dtl.DTLVardef@1e5b755org.highwire.dtl.DTLVardef@676af2org.highwire.dtl.DTLVardef@19e3b34_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

Investigating Bio-Nano Interactions of PEGylated Cationic Polyamidoamine (PAMAM) Dendrimers within Synovial Joints

Delivering therapeutics directly to synovial joints to treat osteoarthritis (OA) is challenging due to the dense negatively charged cartilage matrix and rapid turnover of synovial fluid, leading to high clearance rates. Our lab has identified polyamidoamine (PAMAM) dendrimers as optimal nanocarriers to overcome delivery challenges to cartilage due to their positive charge and small size, which enables them to bind to cartilage and diffuse through tissue to deliver therapeutics to chondrocytes. Previously, we have developed and characterized dendrimers functionalized with polyethylene glycol (PEG), demonstrating improved biocompatibility and enhanced transport through cartilage matrix. To improve the design of our therapeutic system, in this next phase of work, we characterized dendrimer-protein interactions or protein coronas that form on dendrimers after being immersed in synovial fluid. We also analyzed how synovial fluid protein coronas affect biological outcomes of dendrimers in synovial joints, specifically uptake in cartilage and internalization by chondrocytes. We identified that protein coronas can reduce dendrimer uptake in cartilage and chondrocytes; however, uptake reduction is mitigated by varying PEG chain length and density. Although protein coronas can be perceived as "biological barriers" to uptake, we demonstrate that dendrimers conjugated with insulin-like growth factor 1 (IGF-1) have better engagement with IGF-1 receptors after being pre-coated with a synovial fluid protein corona. Overall, these studies offer further insight into the mechanisms of how positively charged dendrimers target and transport through cartilage, bridging knowledge gaps between ex vivo and in vivo work. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=127 SRC="FIGDIR/small/668990v2_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@9298ccorg.highwire.dtl.DTLVardef@6d85aeorg.highwire.dtl.DTLVardef@63838dorg.highwire.dtl.DTLVardef@151ca4a_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

Electrophoresis-Based Approach for Characterizing Dendrimer-Protein Interactions: A Proof-of-Concept Study

Improving the clinical translation of nanomedicine requires better knowledge about how nanoparticles interact with biological environments. As researchers are recognizing the importance of understanding the protein corona and characterizing how nanocarriers respond in biological systems, new tools and techniques are needed to analyze nanocarrier-protein interactions, especially for smaller-size (<10nm) nanoparticles like polyamidoamine (PAMAM) dendrimers. Here we developed a streamlined, semi-quantitative approach to assess dendrimer-protein interactions using a non-denaturing electrophoresis technique combined with mass spectrometry. With this protocol, we detect fluorescently tagged dendrimers and proteins simultaneously, enabling us to analyze when dendrimers migrate with proteins. We found PAMAM dendrimers mostly interact with complement proteins, particularly C3 and C4a, which aligns with previously published data, verifying our approach can be used to isolate and identify dendrimer-protein interactions. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=134 SRC="FIGDIR/small/555747v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@102bdeeorg.highwire.dtl.DTLVardef@103914corg.highwire.dtl.DTLVardef@138402eorg.highwire.dtl.DTLVardef@1fdbbd2_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗